Trial intelligence / Profile preview

Tamsulosin for Postoperative Urinary Retention in Pelvic Surgery

NCT04682366Phase 4Terminated

Sponsor
Wake Forest University Health Sciences
Start
Oct 2021
Primary completion
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in urinary retention comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Number of Participants With Postoperative (Day 0) Urinary Retention. Started Oct 2021; status: terminated.

02

Drugs

tamsulosin
03

Conditions

urinary retention

Beyond the preview

Go deeper on NCT04682366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04682366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call